Recent years have been characterized by wholesale transition in most of the major industries in the developed market economies.
The dynamics of this wave of change have driven old established corporations and start-ups alike to urgently embrace new ways of doing business. These tectonic changes in the environment have created myriad new business opportunities. The traditional arsenal of technological competence and knowledge of corporate players in the target space may no longer be sufficient to craft truly successful business strategies. In order to tap the opportunities of the evolving new economy, today's business ventures can benefit immensely from having access to current information not only about technologies and companies, but also about individuals, support industries, deal structures and the emotions of
the investment and corporate leadership communities.
Gallasus' core activity is identifying market opportunities and helping to design and
forge business relationships for our clients to capitalize on those opportunities.
The company's primary areas of focus are biotechnology, healthcare, diagnostics, therapeutic medical devices, and related areas. Gallasus works with both start-up ventures and large corporations, helping them to navigate the new environment. Companies are encouraged to contact us to exchange thoughts on scientific and industry developments and to explore what creative opportunities might exist.
In addition to the traditional US and European healthcare technology industries, Gallasus also has special insight into the Japanese health science sector. Drawing on the wealth of technology, resources and needs from that environment to complement our Western clients' capabilities is one of our specialties.